Methods for positron emission imaging with radiolabeled...

Details Methods for positron emission imaging with radiolabeled... Methods for positron emission imaging with radiolabeled...

2005-02-03

2008-03-04

Jones, Dameron L. (Department: 1618)

Drug, bio-affecting and body treating compositions

In vivo diagnosis or in vivo testing

X-ray contrast imaging agent

C424S001810, C424S001850, C424S001650, C424S009100, C424S009400, C424S001890, C424S009440, C424S009451

Reexamination Certificate

active

07338652

ABSTRACT:
New diagnostic agents for positron emission tomography (PET) and methods for use of such agents for imaging of human or animal tissue are described, wherein a primary active component of such agents is a radiolabeled halogenated xanthene or halogenated xanthene derivative. Preferably, the radiolabeled halogenated xanthene is radiolabeled Rose Bengal or a functional derivative of Rose Bengal.

REFERENCES:
patent: 6493570 (2002-12-01), Dees et al.
patent: 846674 (1960-08-01), None
PCT International Search Report and Written Opinion for PCT/US05/16836 dated Nov. 17, 2005.

Affiliated with

Also associated with

Rating

Methods for positron emission imaging with radiolabeled... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for positron emission imaging with radiolabeled..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for positron emission imaging with radiolabeled... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3977180